Respirology Search
Respirology Respirology
nontuberculous%20mycobacterial%20disease
NONTUBERCULOUS MYCOBACTERIAL DISEASE
Nontuberculous mycobacteria are ubiquitous and are usually found in soil, natural and treated water sources. They are relatively uncommon cause of pulmonary disease and likely to cause disseminated disease.
May cause both asymptomatic infection and symptomatic disease in humans.
There is no evidence of animal-to-human or human-to-human transmission in immunocompetent hosts.
Nontuberculous mycobacterial pulmonary disease is a generally slowly progressive infection.
Signs and symptoms are generally nonspecific.

Nontuberculous Mycobacterial Disease Drug Information

Drug Information

Indication: Infections of nose-pharynx tract (tonsillitis, pharyngitis) & of paranasal sinuses; lower resp tract: bron...

Indication: Oral: Lower resp tract infections including bronchitis & pneumonia; skin & soft tissue infections; acu...

Indication: Bacterial infections caused by susceptible strains: Community-acquired pneumonia, complicated skin & skin ...

Indication: Lower & upper rest tract, skin & soft tissue infections, acute otitis media. STD, uncomplicated genita...

Indication: Lower resp tract infections eg, bronchitis & pneumonia, odontostomatological, skin & soft tissue infec...

Indication: Purulent bacterial & trachomatous conjunctivitis caused by Chlamydia trachomatis in adults & childn fr...

Indication: Lower resp tract infections including bronchitis & pneumonia; skin & soft tissue infections; otitis me...

Indication: Nasopharyngeal, lower resp tract, skin & soft tissue infections.

Indication: Infections caused by clarithromycin-sensitive pathogens: Nasopharynx (eg, tonsillitis, pharyngitis), paranasal...

Indication: Upper resp tract infections eg, strep pharyngitis/tonsillitis, acute maxillary sinusitis; lower resp tract inf...

1  /  5
1  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Ivermectin improves survival in COVID-19 patients with severe pulmonary involvement
21 Nov 2020
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
COVID-19 vaccine: A saviour, at last?
Pearl Toh, 19 Dec 2020
With the release of the latest interim efficacy results for ChAdOx1 nCoV-19, the adenovirus-vectored vaccine against COVID-19 is inching a step closer towards regulatory approval — and eventually, widespread use that will hopefully put an end to the relentless carnage by the pandemic.
Having asthma or allergy does not increase risk for severe COVID-19
Elvira Manzano, 12 Dec 2020
Having asthma or allergy does not make COVID-19 severe, a new study presented at ACAAI 2020 has shown.
Global race for COVID-19 vaccine gains momentum
Elvira Manzano, 04 Aug 2020
The global race for a COVID-19 vaccine moves at an unprecedented speed, buoyed by public pressure and geopolitical crosscurrents that were punctuated by deaths and infections around the world.